Black Diamond Therapeutics, Inc. (BDTX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17
	10-K	10-K	10-K	10-K	10-K	S-1/A
Revenues [+]	95.1	0.0	0.0	0.0	0.0	0.6
Royalties						0.7
Net interest income						-0.1
Revenue growth					-100.0%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	95.1	0.0	0.0	0.0	0.0	0.6
Gross margin	100.0%					100.0%
Selling, general and administrative [+]	28.4	30.0	21.4	7.6	2.0
General and administrative	28.4	30.0	21.4	7.6	2.0	0.0
Research and development	64.4	96.8	48.2	21.8	7.0
Equity in earnings	-2.3
Other operating expenses	92.8			-6.4	0.0	4.7
EBITDA [+]	-92.3	-126.7	-69.5	-22.9	-8.8	-4.1
EBITDA growth	-27.1%	82.2%	203.7%	158.8%	116.0%
EBITDA margin	-97.1%					-681.4%
Depreciation and amortization	0.5	0.2	0.1	0.0	0.0	0.0
EBIT [+]	-92.8	-126.9	-69.6	-22.9	-8.9	-4.1
EBIT growth	-26.8%	82.4%	203.3%	158.1%	115.8%
EBIT margin	-97.7%					-685.4%
Non-recurring items [+]	2.2			6.4	0.0
Loss (gain) on sale of assets	2.2
Interest income, net [+]	2.0	3.5	4.0	0.5	0.0
Interest expense			0.0
Interest income	2.0	3.5	4.0	0.5	0.0
Other income (expense), net [+]	1.9	-2.2	-1.7	-6.4	0.0	-0.5
Unrealized gain/loss on derivatives				-6.4	0.0
Other	-0.4	-2.2	1.7	0.0	0.0	0.0
Pre-tax income	-91.2	-125.6	-67.3	-35.3	-8.9	-4.6
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-91.2	-125.6	-67.3	-35.3	-8.9	0.0
Net margin	-95.9%					-0.8%

Basic EPS [+]	($2.51)	($3.47)	($2.04)	($16.99)	($4.42)	($2.39)
Growth	-27.7%	69.8%	-88.0%	283.9%	85.0%
Diluted EPS [+]	($2.51)	($3.47)	($2.04)	($16.99)	($4.42)	($2.39)
Growth	-27.7%	69.8%	-88.0%	283.9%	85.0%

Shares outstanding (basic) [+]	36.3	36.2	32.9	2.1	2.0	0.0
Growth	0.4%	10.0%	1485.3%	2.8%	104812.3%
Shares outstanding (diluted) [+]	36.3	36.2	32.9	2.1	2.0	0.0
Growth	0.4%	10.0%	1485.3%	2.8%	104812.3%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.